Clinical Trial Update: A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113) [NA]

View source ↗

Summary

This clinical trial evaluating L-735,524, an HIV protease inhibitor, in combination with interleukin-2 in HIV-infected individuals has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Interleukin-2 (interleukin-2)
• L-735,524 (L-735,524)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | NA | Status: WITHDRAWN